Article info

Download PDFPDF
Extended report
JAK1-dependent transphosphorylation of JAK2 limits the antifibrotic effects of selective JAK2 inhibitors on long-term treatment

Authors

  • Yun Zhang Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Ruifang Liang Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Chih-Wei Chen Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Tatjana Mallano Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Clara Dees Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Alfiya Distler Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Adam Reich Department of Dermatology, Venereology and Allergology, Wrocław Medical University, Wrocław, Poland PubMed articlesGoogle scholar articles
  • Christina Bergmann Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Andreas Ramming Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Kolja Gelse Department of Trauma Surgery, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany PubMed articlesGoogle scholar articles
  • Dirk Mielenz Division of Molecular Immunology, Nikolaus Fiebiger Center, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany PubMed articlesGoogle scholar articles
  • Oliver Distler Division of Rheumatology, University Hospital Zurich, Zurich, Switzerland PubMed articlesGoogle scholar articles
  • Georg Schett Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Jörg H W Distler Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, Erlangen, Germany PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Jörg H W Distler, Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, D-91054 Erlangen, Germany; joerg.distler{at}uk-erlangen.de
View Full Text

Citation

Zhang Y, Liang R, Chen C, et al
JAK1-dependent transphosphorylation of JAK2 limits the antifibrotic effects of selective JAK2 inhibitors on long-term treatment

Publication history

  • Received December 2, 2016
  • Revised February 28, 2017
  • Accepted April 9, 2017
  • First published May 6, 2017.
Online issue publication 
July 11, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.